Medicinal Products (Control of Manufacture) Regulations, 2007

This document cites

• Radiological Protection Act, 1991 (Ionising Radiation) Order, 2000
• European Communities (Clinical Trials on Medicinal Products For Human Use) Regulations, 2004
• European Communities (Amendment of the Irish Medicines Board Act 1995) Regulations, 2007
• European Communities (Medical Ionising Radiation Protection) Regulations, 2002
• Medicinal Products (Control of Placing on the Market) Regulations, 2007



See all quotations

• Medicinal Products (Control of Wholesale Distribution) Regulations, 2007
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
• Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC
• Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products
• Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
• Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products (Text with EEA relevance)
• Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use (Text with EEA relevance)
• Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)
• Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance)
• Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance)
• Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use
• Medical Preparations (Licensing of Manufacture) Regulations, 1993
• Medical Preparations (Licensing of Manufacture) (Amendment) Regulations, 1996
• Health (Alteration of Name of Department and Title of Minister) Order, 1997
• Medical Practitioners Act, 1978
• Medical Preparations (Licensing of Manufacture) Regulations, 1993 (Amendment) Regulations, 1993.